Factor II gene (prothrombin G20210A) mutation and neonatal cerebrovenous thrombosis

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
Issue:2004: 92/4 (Oct) pp. 672-895
Pages:719-721

Factor II gene (prothrombin G20210A) mutation and neonatal cerebrovenous thrombosis

-

-

Summary

The incidence of stroke is reported to be 28 in 100.000 live births. All age groups show an unexplained male predominance. Of the two types of cerebral stroke, arterial ischaemic stroke and (sino-)venous thrombosis, the arterial one is most frequent (1, 2). Non-invasive methods such as ultrasound, computerized-tomography (CT) or magnetic resonance imaging (MRI) can detect these thrombotic events in the brain (3, 4). Etiologic (genetic or acquired) factors predisposing to thrombosis may shift the haemostatic balance towards elevated procoagulant activity resulting in a hypercoagulable state that predisposes to venous or arterial thrombosis. Lower concentrations of antithrombin, protein S and C, along with reduced fibrinolytic capacity, put neonates at greater risk of thromboembolic complications than older children (5).


Articles

You've 428 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...